Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 389,000 | 678,000 | 1,016,000 | 142,000 | 108,000 |
| Cost of Goods | 955,000 | 452,000 | 207,000 | 119,000 | 90,000 |
| Gross Profit | -566,000 | 226,000 | 809,000 | 23,000 | 18,000 |
| Operating Expenses | 822,000 | 1,083,000 | 1,069,000 | 930,000 | 1,068,000 |
| Operating Income | -1,388,000 | -857,000 | -260,000 | -907,000 | -1,050,000 |
| Other Income | 54,000 | 58,000 | 73,000 | 89,000 | 86,000 |
| Pre-tax Income | -1,334,000 | -799,000 | -187,000 | -818,000 | -964,000 |
| Income Tax | 9,000 | 27,000 | 13,000 | 7,000 | 7,000 |
| Net Income Continuous | -1,343,000 | -826,000 | -200,000 | -825,000 | -971,000 |
| Net Income | $-1,343,000 | $-826,000 | $-200,000 | $-825,000 | $-971,000 |
| EPS Basic Total Ops | -3.40 | -2.10 | -0.51 | -2.13 | -2.52 |
| EPS Basic Continuous Ops | -3.40 | -2.10 | -0.51 | -2.13 | -2.52 |
| EPS Diluted Total Ops | -3.40 | -2.10 | -0.51 | -2.13 | -2.52 |
| EPS Diluted Continuous Ops | -3.40 | -2.10 | -0.51 | -2.13 | -2.52 |
| EPS Diluted Before Non-Recurring Items | -1.18 | -2.11 | -0.51 | -2.13 | -2.52 |
| EBITDA(a) | $-1,340,000 | $-803,000 | $-225,000 | $-868,000 | $-1,030,000 |